SuperworthEvolent Health shares outstanding EVH
Diluted shares outstanding, averaged over each quarter, from 2014.
- Latest quarter, to Jun 30, 2026
- 112.5M
- On a year earlier
- −2.9%
- fewer shares
Evolent Health had 112.5M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 2.9% fewer than a year earlier, so each share owns a little more of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 111.6M | −3% |
| FY2024 | 115M | +1% |
| FY2023 | 113.6M | +14% |
| FY2022 | 99.8M | +13% |
| FY2021 | 88.3M | −4% |
| FY2020 | 91.8M | +9% |
| FY2019 | 83.9M | +7% |
| FY2018 | 78.7M | +5% |
| FY2017 | 74.7M | +43% |
| FY2016 | 52.2M | +26% |
| FY2015 | 41.5M | +1436% |
| FY2014 | 2.7M | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 112.5M | −3% | |
| Q1 FY26 | 111.9M | −3% | |
| Q4 FY25 | 111.6M | −3% | |
| Q3 FY25 | 114.1M | −1% | |
| Q2 FY25 | 115.9M | +1% | |
| Q1 FY25 | 115.3M | +1% | |
| Q4 FY24 | 115M | +1% | |
| Q3 FY24 | 114.9M | +2% | |
| Q2 FY24 | 114.7M | +3% | |
| Q1 FY24 | 114.1M | +6% | |
| Q4 FY23 | 113.6M | +14% | |
| Q3 FY23 | 112.3M | +13% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Evolent Health
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.